Kaggen Ausma holds double degrees in Law and Economics.
Prior to joining PYC Therapeutics as chief business officer in July 2019, Mr Ausma spent 4 years at McKinsey and Company across Australia, Asia, and the US where he focused on corporate strategy, venture capital, private equity, and technology in many sectors including life sciences. He had also held a role in the economics team at CLSA Asia-Pacific Markets, a sell-side institutional broking firm based in Hong Kong.